Intravesical electrophoresis of doxorubicin for superficial bladder cancer. Results of prospective randomized trial
https://doi.org/10.17650/1726-9776-2005-1-2-34-40
Abstract
The data of prospective randomized trial including comparative analysis of two treatment arm results are reported. The patients of group A underwent TUR with following intravesical electrophoresis of 50 mg of chemotherapeutic drug Doxorubicin whereas patients of group B were treated with TUR which followed by intravesical instillation of Doxorubicin. Each group included 17 patients with superficial bladder cancer. In group A complete remission were registered in 11 (64,7%), partial regression in 3 (17,6%) and stabilization in 3 (17,6%) patients. In group A complete remission were found in 6 (35,3%), partial regression in 2 (11,8%) and stabilization in 9 (52,9%) patients. Intravesical electrochemotherapy with Doxorubicin is more effective in comparison to standard intravesical chemotherapy with the same drug, which was expressed by higher rate of positive responses to treatment. The positive response rate were 82,4% in group A verse 47,1% in group B, 2-year survival rate was also better in group A (75% verse 51,9%).
About the Authors
A. I. Rolevich
НИИ онкологии и медицинской радиологии им. Н.Н. Александрова
Belarus
Belarus
O. G. Sukonko
НИИ онкологии и медицинской радиологии им. Н.Н. Александрова
Belarus
Belarus
S. A. Krasniy
НИИ онкологии и медицинской радиологии им. Н.Н. Александрова
Belarus
Belarus
A. G. Zhukovets
НИИ онкологии и медицинской радиологии им. Н.Н. Александрова
Belarus
Belarus
References
1. Злокачественные новообразования в Беларуси 1994—2003 гг.: Белорусский канцеррегистр / Под ред. А.А. Граковича и И.В.Залуцкого. — Мн.: БелЦМТ. — 2004. — 203 с.
2. Матвеев Б.П., Фигурин К.М., Карякин О.Б. Рак мочевого пузыря. — М.: Вердана, 2001. — 244 с.
3. Lamm D.L. Long-term results of intravesical therapy for superficial bladder cancer // Urol. Clin. North Am. — 1992. — V. 19. — P. 573-582.
4. Pawinski A., Sylvester R., Kurth K.H. et al. A combined analysis of EORTC/MRC randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer // J. Urol. — 1996. — V. 156(6). — P. 1934—1940.
5. Teruo M., Watanabe H., Kobayashi Т. Absorption of anti-cancer drugs through bladder epithelium // Urology. — 1986. — V. 27. — P. 148—152.
6. Hicks R.M., Ketterer В., Warren R.C. The ultrastructure and chemistry of the luminal plasma membrane of the mammalian urinary bladder: a structure with low permeability to water and ions. Phil. Trans. Roy. Soc. London Biol. Sci. — 1974. — V. 268. — P. 23—28.
7. Stillwell G.K. Electric stimulation and ion-tophoresis. In: Handbook of Physical Medicine and Rehabilitation, 2nd ed. Edited by F. H. Rrussen. St. Louis: W. B. Saunders Co., chapt. 14, 1971.
8. Thiel К.H. Die intravesikale antineoplastische iontophorese Ein unblutiges Verfahren zur Therapie und Rezidivprophylaxe des Blasenkarzinoms. In: Verhandlungsbericht der Deutschen Gesellschaft fur Urologie, 40. Tagung. — Springer Veriag. — 1988.
9. Lugnani F., Mazza G., Cerull N. et al. Iontophoresis of drugs in the bladder wall: equipment and preliminary studies // Artif. Org. — 1993. — V. 17. — P. 8—11.
10. Gurpinar Т., Truong L.D., Wong H.Y., Griffith D.P. Electromotive drug administration to the urinary bladder: an animal model and preliminary results // J. Urol. — 1996. — V. 156. — P. 1496—1501.
11. Riedl C.R., Knoll M., Pfluger H. Detrusor stimulation by intravesical EMDA of bethanechol. // J. Endourol. — 1996. — V. 10 (suppl.). — P. 236.
12. Di Stasi S.M., Vespasiani G., Giannantoni A. et al. Electromotive delivery of mitomycin C into human bladder wall // Cancer Res. — 1997. — V. 57. — P. 875—879.
13. Di Stasi S.M., Giannantoni A., Massoud R. et al. Electromotive administration of oxybutynin into the human bladder wall // J. Urol. — 1997. — V. 158. — P. 228—234.
14. Di Stasi S.M., Castagnola M., Vespasiani G. et al. In vitro study of passive vs electromotive mitomycin С diffusion in human bladder wall. Preliminary results // J. Urol. — 1994. — V. 151. — P. 447A.
15. Dasgupta P., Fowler C.J., Hoverd P. et al. Does electromotive drug administration (EMDA) with lidocaine before intravesical capsaicin confer benefit? // J. Urol. — 1997. — V. 157, part 2 — P. 186, abstract 724.
16. Gurpinar Т., Wong H.Y., Griffith D.P. Electromotive administration of intravesical lidocaine in patients with interstitial cystitis // J. Endourol. — 1996. — V. 10. — P. 443—447.
17. Fontanella U.A., Rossi C.A., Stephen R.L. Bladder and urethral anesthesia with electromotive drug administration (EMDA): a technique for invasive endoscopic procedures // Brit. J. Urol. — 1997. — V. 79. — P. 414—419.
18. Jewett M.A.S., Valiquette L., Katz J. et al. Electromotive drug administration (EMDA) of lidocaine as an alternative anesthesia for transurethral surgery // J. Urol. — 1997. — V. 157, part 2. — P. 273, abstract 1059.
19. Fontanella U.A., Rossi C.A., Stephen R.L. Iontophoretic local anesthesia for bladder dilatation in the treatment of interstitial cystitis // Brit. J. Urol. — 1992. — V. 69. — P. 662—669.
20. Sant G.R., LaRock D.R. Standard intravesical therapies for interstitial cystitis // Urol. Clin. N. Amer. — 1994. — V. 21. — P. 73—84.
21. Riedl C.R., Knoll M., Plas E., Pfluger H. Intravesical electromotive drug administration technique: Preliminary results and side effects // J. Urol. — 1998. — V. 159. — P. 1851—1856.
22. Brausi M., Campo B., Pizzocaro G. et al. Intravesical electromotive administration of drugs for treatment of superficial bladder cancer: A comparative phase II study. // Urology. — 1998. — V. 51. — P. 506—509.
23. Colombo R., Brausi M., Da Pozzo L.F. et al. Thermo-Chemotherapy and Electromotive Drug Administration of Mitomycin С in Superficial Bladder Cancer Eradication. A Pilot Study on Marker Lesion // Eur. Urol. — 2001. — V. 39. — P. 95—100.
24. Di Stasi S., Giannantoni A., Stephen R. et al. Intravesical electromotive mitomycin c versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study // J. Urol. — 2003. — V. 170. — P. 777—782.
25. Eksborg S. Extraction of daunorubicin and doxorubicin and their hydroxyl metabolites. Self-association in aqueous solution // J. Pharm. Sci. — 1978. — V. 67. — P. 782—785.
26. Luxenberg M.N., Guthrie T.H. Jr. Chemotherapy of basal cell and squamous cell carcinoma of the eyelids and periorbital tissues // Ophthalmology. — 1986. — V. 93(4). — P. 504—510.
27. Nordenstrom B.E., Eksborg S., Beving H. Electrochemical treatment of cancer. II: Effect of electrophoretic influence on adriamycin // Am. J. Clin. Oncol. — 1990. — V. 13 (1). — P. 75—88.
28. Di Stasi S.M., Giannantoni A., Massoud R. et al. Electromotive versus passive diffusion of mitomycin C into human bladder wall: concentration-depth profiles studies // Cancer Res. — 1999. — V. 59. — P. 4912—4916.
29. Van der Meijden A.P.M., Hall R.R., Kurth K.H., Bouffioux C.H., Sylvester R. and members of the EORTC Genitourinary Group. Phase II trials in Та, Т1 bladder cancer. The marker tumour concept // British Journal of Urology. — 1996. — V. 77. — P. 634—637.
Review
For citations:
Rolevich A.I., Sukonko O.G., Krasniy S.A., Zhukovets A.G. Intravesical electrophoresis of doxorubicin for superficial bladder cancer. Results of prospective randomized trial. Cancer Urology. 2005;1(2):34-40. (In Russ.) https://doi.org/10.17650/1726-9776-2005-1-2-34-40
Views:
285
Email this article 